Eurican DAP inj. susp. (lyoph. + solv.) s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurican dap inj. susp. (lyoph. + solv.) s.c. vial

boehringer ingelheim animal health belgium sa-nv - canine parvovirus (live, attenuated) ; canine distemper virus (live, attenuated) ; canine adenovirus 2 (live, attenuated) - lyophilisate and solvent for suspension for injection - canine distemper virus (cdv); canine adenovirus type 2; canine parvovirus type 2 - canine distemper virus + canine adenovirus + canine parvovirus - dog

Eurican DAPPi inj. susp. (lyoph. + solv.) s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurican dappi inj. susp. (lyoph. + solv.) s.c. vial

boehringer ingelheim animal health belgium sa-nv - canine distemper virus (live, attenuated) ; canine parvovirus (live, attenuated) ; canine parainfluenzavirus (live, attenuated) ; canine adenovirus 2 (live, attenuated) - lyophilisate and solvent for suspension for injection - canine distemper virus (cdv); canine adenovirus type 2; canine parainfluenza virus type 2; canine parvovirus type 2 - canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus - dog

Nobivac DHP inj. susp. (lyoph. + solv.) s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nobivac dhp inj. susp. (lyoph. + solv.) s.c. vial

intervet international b.v. - canine distemper virus, live, strain onderstepoort ; canine parvovirus (live, attenuated) ; canine adenovirus 2 (live, attenuated) - lyophilisate and solvent for suspension for injection - canine parvovirus; canine adenovirus type 2; canine distemper virus (cdv) - canine distemper virus + canine adenovirus + canine parvovirus - dog

Nobivac DHPPI inj. susp. (lyoph. + solv.) s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nobivac dhppi inj. susp. (lyoph. + solv.) s.c. vial

intervet international b.v. - canine adenovirus 2 (live, attenuated) ; canine distemper virus (live, attenuated) ; canine parvovirus (live, attenuated) ; canine parainfluenza virus, live, strain cornell - lyophilisate and solvent for suspension for injection - canine parainfluenza virus, live, strain cornell; canine parvovirus; canine distemper virus (cdv); canine adenovirus type 2 - canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus - dog

Vanguard DA2PI-CPV inj. susp. (lyoph. + solv.) s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vanguard da2pi-cpv inj. susp. (lyoph. + solv.) s.c. vial

zoetis belgium - canine parainfluenza virus, live, strain nl-cpi-5 = 10exp6.0 ccid50/do; canine distemper virus (live, attenuated) = 10exp3.0 ccid50/dose; canine parvovirus (live, attenuated) = 10exp7.0 ccid50/dose; canine adenovirus 2 (live, attenuated) = 10exp3.2 ccid50/dose - lyophilisate and solvent for suspension for injection - canine parvovirus; canine parainfluenza virus, live, strain nl-cpi-5; canine adenovirus type 2; canine distemper virus (cdv) - canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus - dog

Versican Plus DHP inj. susp. (lyoph. + solv.) s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

versican plus dhp inj. susp. (lyoph. + solv.) s.c. vial

zoetis belgium sa-nv - canine adenovirus 2 (live, attenuated) ; canine parvovirus (live, attenuated) ; canine distemper virus (live, attenuated) - lyophilisate and solvent for suspension for injection - canine distemper virus (cdv); canine adenovirus type 2; canine parvovirus type 2b - canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus - dog

Nobivac DP Plus European Union - English - EMA (European Medicines Agency)

nobivac dp plus

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immunologicals for canidae - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

VANGUARD 5 New Zealand - English - Ministry for Primary Industries

vanguard 5

zoetis new zealand limited - canine parvovirus (attenuated); canine distemper virus (attenuated); canine parainfluenza virus (attenuated); canine adenovirus type 2 (attenuated) - canine parvovirus (attenuated) 0 vaccine; canine distemper virus (attenuated) 0 vaccine; canine parainfluenza virus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine - vaccine

VANGUARD Plus 5 New Zealand - English - Ministry for Primary Industries

vanguard plus 5

zoetis new zealand limited - canine parvovirus (attenuated); canine parainfluenza virus (attenuated); canine adenovirus type 2 (attenuated); canine distemper virus (attenuated) - canine parvovirus (attenuated) 0 vaccine; canine parainfluenza virus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine; canine distemper virus (attenuated) 0 vaccine - vaccine

CANIXIN DHPPi lyophilisate and solvent for suspension for injection for dogs Ireland - English - HPRA (Health Products Regulatory Authority)

canixin dhppi lyophilisate and solvent for suspension for injection for dogs

virbac s.a. - canine distemper virus (lederle strain); canine parvovirus (cpv 780916 strain); canine adenovirus type 2 (manhattan strain); canine parainfluenza (manhattan strain) - lyophilisate and solvent for suspension for injection - . cell culture infective dose 50 - canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus - dogs - immunological - live vaccine